Commodore Capital’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,025,000
| Closed | -$22.2M | – | 33 |
|
|
2023
Q2 | $22.2M | Hold |
2,025,000
| – | – | 2.49% | 12 |
|
|
2023
Q1 | $17.7M | Sell |
2,025,000
-3,713,500
| -65% | -$32.4M | 2.69% | 14 |
|
|
2022
Q4 | $36M | Hold |
5,738,500
| – | – | 5.42% | 6 |
|
|
2022
Q3 | $20.1M | Hold |
5,738,500
| – | – | 3.23% | 11 |
|
|
2022
Q2 | $16.9M | Hold |
5,738,500
| – | – | 3.58% | 11 |
|
|
2022
Q1 | $17.8M | Buy |
5,738,500
+318,604
| +6% | +$991K | 3.99% | 9 |
|
|
2021
Q4 | $18.3M | Buy |
5,419,896
+1,250,000
| +30% | +$4.22M | 4.24% | 9 |
|
|
2021
Q3 | $15.2M | Buy |
4,169,896
+640,431
| +18% | +$2.34M | 4.01% | 10 |
|
|
2021
Q2 | $15.4M | Buy |
3,529,465
+545,952
| +18% | +$2.38M | 5.36% | 5 |
|
|
2021
Q1 | $13.5M | Buy |
2,983,513
+1,497,406
| +101% | +$6.8M | 5.4% | 6 |
|
|
2020
Q4 | $8.53M | Buy |
+1,486,107
| New | +$8.53M | 4.64% | 9 |
|